These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8274244)

  • 21. LPS-induced sTNF-receptor release in vivo in a murine model. Investigation of the role of tumor necrosis factor, IL-1, leukemia inhibiting factor, and IFN-gamma.
    Bemelmans MH; Gouma DJ; Buurman WA
    J Immunol; 1993 Nov; 151(10):5554-62. PubMed ID: 8228246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytokines and soluble cytokine receptors in pleural effusions from septic and nonseptic patients.
    Marie C; Losser MR; Fitting C; Kermarrec N; Payen D; Cavaillon JM
    Am J Respir Crit Care Med; 1997 Nov; 156(5):1515-22. PubMed ID: 9372669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma endotoxin and cytokine levels in neutropenic and non-neutropenic bacteremic patients.
    Hynninen M; Valtonen M; Vaara M; Markkanen H; Kuusela P; Saxen H; Takkunen O
    Eur J Clin Microbiol Infect Dis; 1995 Dec; 14(12):1039-45. PubMed ID: 8681977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-1ra suppresses endotoxin-induced IL-1 beta and TNF-alpha release from mononuclear phagocytes.
    Marsh CB; Moore SA; Pope HA; Wewers MD
    Am J Physiol; 1994 Jul; 267(1 Pt 1):L39-45. PubMed ID: 8048540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of cytokines in osteoarthritis pathophysiology.
    Fernandes JC; Martel-Pelletier J; Pelletier JP
    Biorheology; 2002; 39(1-2):237-46. PubMed ID: 12082286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of the inflammatory cytokine network among TNF alpha, IL-1 beta, IL-1 receptor antagonist, and IL-8 in LPS-induced rabbit arthritis.
    Matsukawa A; Yoshimura T; Miyamoto K; Ohkawara S; Yoshinaga M
    Lab Invest; 1997 May; 76(5):629-38. PubMed ID: 9166282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma concentration of cytokine antagonists in patients with infection following liver resection.
    Kimura F; Miyazaki M; Suwa T; Sugiura T; Shinoda T; Itoh H; Ambiru S; Shimizu H; Nakagawa K
    Br J Surg; 1998 Dec; 85(12):1631-5. PubMed ID: 9876064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor necrosis factor and interleukin-1 inhibitors as markers of disease activity of tuberculosis.
    Juffermans NP; Verbon A; van Deventer SJ; van Deutekom H; Speelman P; van der Poll T
    Am J Respir Crit Care Med; 1998 Apr; 157(4 Pt 1):1328-31. PubMed ID: 9563758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential hazards of combination immunotherapy in the treatment of experimental septic shock.
    Opal SM; Cross AS; Jhung JW; Young LD; Palardy JE; Parejo NA; Donsky C
    J Infect Dis; 1996 Jun; 173(6):1415-21. PubMed ID: 8648214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease.
    Fischer E; Van Zee KJ; Marano MA; Rock CS; Kenney JS; Poutsiaka DD; Dinarello CA; Lowry SF; Moldawer LL
    Blood; 1992 May; 79(9):2196-200. PubMed ID: 1533321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-1 contributes to increased concentrations of soluble tumor necrosis factor receptor type I in sepsis.
    van der Poll T; Fischer E; Coyle SM; Van Zee KJ; Pribble JP; Stiles DM; Barie PS; Buurman WA; Moldawer LL; Lowry SF
    J Infect Dis; 1995 Aug; 172(2):577-80. PubMed ID: 7622910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduction of inflammation by decreasing production of interleukin-1 or by specific receptor antagonism.
    Dinarello CA
    Int J Tissue React; 1992; 14(2):65-75. PubMed ID: 1399323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period.
    Kimble RB; Matayoshi AB; Vannice JL; Kung VT; Williams C; Pacifici R
    Endocrinology; 1995 Jul; 136(7):3054-61. PubMed ID: 7789332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor necrosis factor-alpha is not essential in endotoxin induced eye inflammation: studies in cytokine receptor deficient mice.
    Rosenbaum JT; Han YB; Park JM; Kennedy M; Planck SR
    J Rheumatol; 1998 Dec; 25(12):2408-16. PubMed ID: 9858438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Release of anti-inflammatory mediators after mechanical trauma correlates with severity of injury and clinical outcome.
    Ertel W; Keel M; Bonaccio M; Steckholzer U; Gallati H; Kenney JS; Trentz O
    J Trauma; 1995 Nov; 39(5):879-85; discussion 885-7. PubMed ID: 7474003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship of plasma leptin to plasma cytokines and human survivalin sepsis and septic shock.
    Arnalich F; López J; Codoceo R; Jim nez M; Madero R; Montiel C
    J Infect Dis; 1999 Sep; 180(3):908-11. PubMed ID: 10438392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Soluble cytokine receptors and the low 3,5,3'-triiodothyronine syndrome in patients with nonthyroidal disease.
    Boelen A; Platvoet-Ter Schiphorst MC; Wiersinga WM
    J Clin Endocrinol Metab; 1995 Mar; 80(3):971-6. PubMed ID: 7883859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A matrix metalloproteinase inhibitor prevents processing of tumor necrosis factor alpha (TNF alpha) and abrogates endotoxin-induced lethality.
    Solorzano CC; Ksontini R; Pruitt JH; Auffenberg T; Tannahill C; Galardy RE; Schultz GP; MacKay SL; Copeland EM; Moldawer LL
    Shock; 1997 Jun; 7(6):427-31. PubMed ID: 9185243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytokine-induced interleukin-1 receptor antagonist release in mononuclear phagocytes.
    Marsh CB; Wewers MD
    Am J Respir Cell Mol Biol; 1994 May; 10(5):521-5. PubMed ID: 8179914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options.
    Gogos CA; Drosou E; Bassaris HP; Skoutelis A
    J Infect Dis; 2000 Jan; 181(1):176-80. PubMed ID: 10608764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.